FABP6-AS1

Across TCGA pan-cancer cohorts, FABP6-AS1 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated FABP6-AS1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher FABP6-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated FABP6-AS1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and KIRC show a favorable association.

BLCA, DLBC, and BRCA are the cancer types where FABP6-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Quartile	All	0.775	0.590	<.001	93	view →
DLBC	DFS	Tertile	II,III,IV	0.070	0.887	<.001	51	view →
BRCA	OS	Tertile	II,III,IV	0.943	0.964	.007	46	view →
LGG	OS	Median	All	0.854	0.932	<.001	37	view →
KIRC	OS	Median	II,III,IV	0.632	0.460	.005	33	view →
MESO	DFS	Quartile	IV	0.079	0.456	<.001	21	view →
HNSC	DFS	Tertile	II,III,IV	0.665	0.548	.023	19	view →
SKCM	OS	Tertile	III,IV	0.732	0.840	.017	16	view →
CHOL	OS	Median	All	0.374	0.710	.014	16	view →
COAD	OS	Median	IV	0.768	0.278	.008	16	view →
ACC	OS	Quartile	II,III,IV	1.000	0.362	.003	14	view →
THYM	OS	Quartile	All	0.668	1.000	.011	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

FABP6-AS1–BLCA (OS)

Open the BLCA breakdown →